Trials / Conditions / Transthyretin Amyloid Cardiopathy
Transthyretin Amyloid Cardiopathy
4 registered clinical trials studyying Transthyretin Amyloid Cardiopathy.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | ATTR-CM: A Multi-country, Non-interventional Disease Registry NCT06651073 | Pfizer | — |
| Completed | The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Pa NCT05633563 | Steen Hvitfeldt Poulsen | Phase 4 |
| Withdrawn | ION-682884 in Patients With TTR Amyloid Cardiomyopathy NCT04843020 | Brigham and Women's Hospital | Phase 2 |
| Withdrawn | Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP) NCT02713880 | CENTOGENE GmbH Rostock | — |